Inspection Record

HK Kolmar Canada, Inc. — Health Canada Inspection Findings

Health CanadaInspected 2024-09-09 13 findingsMaterial and supplier controlTraining and personnelLaboratory and QC controlsEquipment and facilityOther quality systemComputer system validationDeviation, CAPA, and investigation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Material and supplier control

The premises were not designed, constructed, operated, and/or maintained to prevent contamination. The premises were not constructed and/or maintained to allow cleaning and/or prevent the accumulation of foreign material.

2Training and personnel

The ongoing training of personnel was inadequate.

3Laboratory and QC controls

The receipt, preparation, and/or handling of reagents and culture media was inadequate. The creation, maintenance, processing, and/or review of laboratory data was inadequate. The design, equipment, and/or maintenance of the testing laboratory was inadequate.

4Equipment and facility

Evaluation of production processes, equipment, and/or materials was inadequate.

5Other quality system

The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate.

6Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

7Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate. Measuring devices were not regularly checked for accuracy and precision. The equipment was not set-up, designed, operated, stored, and/or maintained to prevent potential contamination of drugs by other drugs and/or by foreign material.

8Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

9Other quality system

The implementation of a self-inspection program was inadequate.

10Other quality system

The master production documents were inadequate. The recorded information or details were inadequate.

11Laboratory and QC controls

The quality control department's approval was inadequate for raw materials, packaging materials, labelling, finished products, and/or products being reprocessed.

12Laboratory and QC controls

The quarantine, sampling, testing, release of raw material, and/or the packaging materials prior to use were inadequate. The quality control department was not involved in all decisions for the quality of the product.

13Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate. The quality control department did not appropriately approve, assess, and/or document the reprocessing and/or reworking of a lot and/or batch.

About this record

Extracted automatically from the document of the Health Canada inspection on 2024-09-09. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

HK Kolmar Canada, Inc. company profile — full history Health Canada documents, 2024 Go to Findings search